INBS - INTELLIGENT BIO SOLUTIONS INC.

4.98
-0.300   -6.024%

Share volume: 23,840
Last Updated: 12-24-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$5.28
-0.30
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 42%
Liquidity 18%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-13.39%
1 Month
653.63%
3 Months
289.06%
6 Months
191.23%
1 Year
245.81%
2 Year
1,387.46%
Key data
Stock price
$4.98
P/E Ratio 
0.00
DAY RANGE
$4.92 - $5.36
EPS 
-$1.99
52 WEEK RANGE
$0.54 - $7.25
52 WEEK CHANGE
$245.81
MARKET CAP 
9.159 M
YIELD 
N/A
SHARES OUTSTANDING 
9.453 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
2.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$97,643
AVERAGE 30 VOLUME 
$137,730
Company detail
CEO: Harry Simeonidis
Region: US
Website: gbs.inc
Employees: 10
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company was incorporated in 2016 and is headquartered in New York, New York.

Recent news